XTL Biopharmaceuticals Statistics

Total Valuation

TLV:XTLB has a market cap or net worth of ILS 40.54 million. The enterprise value is 36.88 million.

Market Cap	40.54M
Enterprise Value	36.88M

Important Dates

The last earnings date was Monday, May 12, 2025.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TLV:XTLB has 881.39 million shares outstanding. The number of shares has increased by 29.23% in one year.

Current Share Class	881.39M
Shares Outstanding	881.39M
Shares Change (YoY)	+29.23%
Shares Change (QoQ)	+22.96%
Owned by Insiders (%)	14.94%
Owned by Institutions (%)	2.72%
Float	749.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.68
PB Ratio	2.05
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.86
EV / Sales	22.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.06

Financial Position

The company has a current ratio of 0.61, with a Debt / Equity ratio of 0.03.

Current Ratio	0.61
Quick Ratio	0.56
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-77.57

Financial Efficiency

Return on equity (ROE) is -26.83% and return on invested capital (ROIC) is -34.84%.

Return on Equity (ROE)	-26.83%
Return on Assets (ROA)	-24.74%
Return on Invested Capital (ROIC)	-34.84%
Return on Capital Employed (ROCE)	-34.24%
Revenue Per Employee	164,268
Profits Per Employee	-374,064
Employee Count	5
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.78% in the last 52 weeks. The beta is 1.04, so TLV:XTLB's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-47.78%
50-Day Moving Average	4.67
200-Day Moving Average	6.61
Relative Strength Index (RSI)	51.72
Average Volume (20 Days)	563,727

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TLV:XTLB had revenue of ILS 1.64 million and -3.74 million in losses. Loss per share was -0.01.

Revenue	1.64M
Gross Profit	10,927
Operating Income	-7.91M
Pretax Income	-4.21M
Net Income	-3.74M
EBITDA	-7.19M
EBIT	-7.91M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 4.16 million in cash and 502,637 in debt, giving a net cash position of 3.66 million or 0.00 per share.

Cash & Cash Equivalents	4.16M
Total Debt	502,637
Net Cash	3.66M
Net Cash Per Share	0.00
Equity (Book Value)	19.80M
Book Value Per Share	0.02
Working Capital	-3.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.89 million and capital expenditures -196,684, giving a free cash flow of -6.09 million.

Operating Cash Flow	-5.89M
Capital Expenditures	-196,684
Free Cash Flow	-6.09M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 0.67%, with operating and profit margins of -481.60% and -227.72%.

Gross Margin	0.67%
Operating Margin	-481.60%
Pretax Margin	-256.54%
Profit Margin	-227.72%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:XTLB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.23%
Shareholder Yield	-29.23%
Earnings Yield	-9.23%
FCF Yield	-15.02%

Stock Splits

The last stock split was on June 22, 2009. It was a reverse split with a ratio of 0.2.

Last Split Date	Jun 22, 2009
Split Type	Reverse
Split Ratio	0.2

Scores

TLV:XTLB has an Altman Z-Score of -23.68. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-23.68
Piotroski F-Score	n/a